Catalyst Wire Dossier Catalyst Wire Dossier

varicella vaccines (GlaxoSmithKline two-dose regimens)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for varicella vaccines (GlaxoSmithKline two-dose regimens), covering 2017-10-11 to 2017-10-11. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. [Phase 3]

See pricing